Keywords: generic, ranitidine, finally, launched, onto, market, glaxo

Generic Ranitidine Finally Launched Onto US Market

Article | 04 August 1997

Print This

Glaxo Wellcome's exclusivity for its H2 receptor antagonist Zantac(ranitidine) in the USA came to an end on July 31, after ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in